Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Appointed director
|
|
Ocera Therapeutics, Inc. (OCRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Ocera Therapeutics, Inc. |
| 12/21/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/14/2017 |
SC 13D/A
| Domain Partners VIII, L.P. reports a 0% stake in Ocera Therapeutics, Inc. |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/13/2017 |
4
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 47,963 shares
@ $0 |
|
| 12/13/2017 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 15,731 shares
@ $0 |
|
| 12/13/2017 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 1,857,036 shares
@ $0
Disposed/sold 20,150 options to buy
@ $0.67, valued at
$13.5k
|
|
| 12/13/2017 |
4
| DP VIII Associates, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 7,333 shares
@ $0 |
|
| 12/13/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 988,285 shares
@ $0 |
|
| 12/11/2017 |
4
| Grais Linda S (President and CEO) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 230,000 shares
@ $1.52, valued at
$349.6k
Disposed/sold 70,000 shares
@ $1.52, valued at
$106.4k
Disposed/sold 289,200 options to buy
@ $2.15, valued at
$621.8k
Disposed/sold 348,600 options to buy
@ $2.98, valued at
$1M
Disposed/sold 160,000 options to buy
@ $3.76, valued at
$601.6k
Disposed/sold 491,550 options to buy
@ $7.38, valued at
$3.6M
Disposed/sold 37,500 options to buy
@ $7.84, valued at
$294k
Disposed/sold 30,826 options to buy
@ $0.67, valued at
$20.7k
Disposed/sold 30,827 options to buy
@ $0.67, valued at
$20.7k
Disposed/sold 11,969 options to buy
@ $0.67, valued at
$8k
|
|
| 12/11/2017 |
4
| Kjellson Nina S (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 20,000 options to buy
@ $7.85, valued at
$157k
Disposed/sold 10,000 options to buy
@ $7.84, valued at
$78.4k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
| 12/11/2017 |
4
| Bukofzer Stan (Chief Medical Officer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 2,500 shares
@ $1.52, valued at
$3.8k
Disposed/sold 200,000 shares
@ $1.52, valued at
$304k
Disposed/sold 300,000 options to buy
@ $3.06, valued at
$918k
Disposed/sold 208,350 options to buy
@ $2.15, valued at
$448k
|
|
| 12/11/2017 |
4
| James Steven P (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 20,000 options to buy
@ $5.51, valued at
$110.2k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
| 12/11/2017 |
4
| Byrnes Michael (CFO and Treasurer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 13,000 shares
@ $1.52, valued at
$19.8k
Disposed/sold 150,000 shares
@ $1.52, valued at
$228k
Disposed/sold 123,300 options to buy
@ $2.98, valued at
$367.4k
Disposed/sold 55,000 options to buy
@ $7.5, valued at
$412.5k
Disposed/sold 75,000 options to buy
@ $3.76, valued at
$282k
Disposed/sold 102,300 options to buy
@ $2.15, valued at
$219.9k
Disposed/sold 70,000 options to buy
@ $7.5, valued at
$525k
|
|
| 12/11/2017 |
4
| Dere Willard H (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 20,000 options to buy
@ $2.425, valued at
$48.5k
|
|
| 12/11/2017 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
Disposed/sold 20,000 options to buy
@ $7.85, valued at
$157k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 2,083 options to buy
@ $48, valued at
$100k
Disposed/sold 2,652 options to buy
@ $50.88, valued at
$134.9k
Disposed/sold 10,000 options to buy
@ $7.84, valued at
$78.4k
|
|
| 12/11/2017 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 344,719 shares
@ $1.52, valued at
$524k
Disposed/sold 11,969 shares
@ $1.52, valued at
$18.2k
Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 2,992 options to buy
@ $1.84, valued at
$5.5k
Disposed/sold 20,000 options to buy
@ $7.85, valued at
$157k
Disposed/sold 10,000 options to buy
@ $7.84, valued at
$78.4k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
| 12/11/2017 |
4
| WIERENGA WENDALL (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 5,000 shares
@ $1.52, valued at
$7.6k
Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 20,000 options to buy
@ $13.25, valued at
$265k
Disposed/sold 10,000 options to buy
@ $7.84, valued at
$78.4k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 12/11/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 12/11/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/11/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
|
|
|